Simplex Trading
NRIX icon

Simplex Trading’s Nurix Therapeutics NRIX Stock Holding History

Simplex Trading’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Sell
900
-1,400
-61% -$23.2K ﹤0.01% 7055
2025
Q4 		$43.6K Buy
+2,300
New +$33K ﹤0.01% 5786
2025
Q3 		– Sell
-3,900
Closed -$44K – 9729
2025
Q2 		$44K Buy
3,900
+3,700
+1,850% +$40K ﹤0.01% 6046
2025
Q1 		$2K Sell
200
-1,100
-85% -$18.4K ﹤0.01% 8032
2024
Q4 		$24K Buy
+1,300
New +$29.8K ﹤0.01% 6539
2024
Q3 		– Sell
-3,400
Closed -$70K – 9219
2024
Q2 		$70K Buy
3,400
+3,300
+3,300% +$51.4K ﹤0.01% 5736
2024
Q1 		$1K Buy
+100
New +$1.08K ﹤0.01% 8611
2022
Q4 		– Sell
-100
Closed -$1K – 10008
2022
Q3 		$1K Buy
+100
New +$1.58K ﹤0.01% 9591
2022
Q1 		– Sell
-100
Closed -$2K – 11085
2021
Q4 		$2K Sell
100
-400
-80% -$12.1K ﹤0.01% 10016
2021
Q3 		$13K Hold
500
– – ﹤0.01% 8764
2021
Q2 		$13K Buy
500
+494
+8,233% +$14.5K ﹤0.01% 8923
2021
Q1 		$18K Buy
+6
New +$227 ﹤0.01% 7538

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Simplex Trading's NRIX Position: Q1 2026 in Review

Simplex Trading reduced its Nurix Therapeutics (NRIX) stake by 66% in Q1 2026, selling an estimated $262K and leaving 8,113 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4816.

Simplex Trading first reported a position in NRIX in Q1 2021 and has held it in 16 quarters since. The position peaked at $453K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Simplex Trading held 8,113 shares of Nurix Therapeutics worth $126K as of Q1 2026.
  • Simplex Trading sold 15,772 Nurix Therapeutics shares in Q1 2026, an estimated $262K.
  • Nurix Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4816 holding.
  • Simplex Trading first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Simplex Trading's Nurix Therapeutics position peaked at $453K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.